September 29, 2020

Aprea Therapeutics Appoints Michael A. Kelly to Board of Directors

BOSTON, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics Inc., (NASDAQ: APRE), a clinical-stage biotechnology company focused on developing and commercializing novel cance...
Read more
September 29, 2020

Fusion Pharmaceuticals Appoints Maria Stahl As Chief Legal Officer

HAMILTON, ON and BOSTON, Sept. 29, 2020 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-...
Read more
September 28, 2020

GenSight Biologics Announces Publication of Meta-Analysis Confirming that Spontaneous Recovery in LHON is rare in the Journal of Neuro-Ophthalmology

Paris, France, September 28, 2020, 7:30 am CEST – GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing...
Read more
September 25, 2020

Invitation – Orexo Digital Therapeutics business update October 1

Uppsala, Sweden – September 25, 2020 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today invites investors, analysts, and media to attend a teleconference on Thursday Octobe...
Read more
September 25, 2020

Robust effects of VP01 in human idiopathic pulmonary fibrosis lung tissue

Gothenburg, September 25, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announc...
Read more
September 23, 2020

Vivet Therapeutics and Pfizer Inc. Enter into Manufacturing Agreement for Vivet’s Investigational Gene Therapy for Wilson Disease

PARIS, France and NEW YORK, N.Y.—September 23, 2020— Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing treatments for inhe...
Read more
September 23, 2020

Nordic Nanovector ASA – Key information regarding potential repair offering

Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia THIS IS A RESTRICTED COMMUNICATION AN...
Read more
September 23, 2020

Nordic Nanovector – Private placement successfully completed

Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia THIS IS A RESTRICTED COMMUNICATION AN...
Read more
September 22, 2020

Digital Therapies Help Frontline Workers Cope

September 22, 2020 Trinity Health employees who may be struggling to manage stress related to the coronavirus pandemic now have new tools available to help them cope. Trini...
Read more
September 21, 2020

Camel-IDS enters next stage with name change to PRECIRIX® and IND approval for CAM-H2 Phase I/II study

New corporate identity to better reflect the company’s advanced stage IND approval allows initiation of Phase I/II clinical trial with lead compound CAM-H2 in advanced/metasta...
Read more